Search research articles
Contact Us
Filters
Showing results (51-60 of 140) with videos related to
Page
of 14
Sort By:
Cancer Research
|
April 17, 2021
SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243
Yasuhisa Murai, Ukhyun Jo, Junko Murai, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 25, 2025
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids
Thomas S Dexheimer, Zahra Davoudi, Nathan P Coussens, et al.
Investigational New Drugs
|
October 10, 2017
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial
Dana B Cardin, Laura W Goff, Emily Chan, et al.
Leukemia & Lymphoma
|
May 15, 2015
Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia
Jennifer R Brown, Bethany Tesar, Lijian Yu, et al.
American Journal of Hematology
|
June 4, 2014
Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia
Lori A Gardner, Jelena Klawitter, Mark A Gregory, et al.
Cancer Research Communications
|
July 23, 2024
Acetalax (Oxyphenisatin Acetate, NSC 59687) and Bisacodyl Cause Oncosis in Triple-Negative Breast Cancer Cell Lines by Poisoning the Ion Exchange Membrane Protein TRPM4
Makito Mizunuma, Christophe E Redon, Liton Kumar Saha, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network
Jeffrey Abrams, Barbara Conley, Margaret Mooney, et al.
Radiation Research
|
April 7, 2021
SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma Multiforme
David Cerna, Bora Lim, Yusuf Adelabu, et al.
Investigational New Drugs
|
July 18, 2013
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer
William R Schelman, Tabraiz A Mohammed, Anne M Traynor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients
Naoko Takebe, Xiangfei Cheng, Suhlan Wu, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 140) with videos related to
Sort By:
Page
of 14
Cancer Research
|
April 17, 2021
SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243
Yasuhisa Murai, Ukhyun Jo, Junko Murai, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 25, 2025
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids
Thomas S Dexheimer, Zahra Davoudi, Nathan P Coussens, et al.
Investigational New Drugs
|
October 10, 2017
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial
Dana B Cardin, Laura W Goff, Emily Chan, et al.
Leukemia & Lymphoma
|
May 15, 2015
Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia
Jennifer R Brown, Bethany Tesar, Lijian Yu, et al.
American Journal of Hematology
|
June 4, 2014
Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia
Lori A Gardner, Jelena Klawitter, Mark A Gregory, et al.
Cancer Research Communications
|
July 23, 2024
Acetalax (Oxyphenisatin Acetate, NSC 59687) and Bisacodyl Cause Oncosis in Triple-Negative Breast Cancer Cell Lines by Poisoning the Ion Exchange Membrane Protein TRPM4
Makito Mizunuma, Christophe E Redon, Liton Kumar Saha, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network
Jeffrey Abrams, Barbara Conley, Margaret Mooney, et al.
Radiation Research
|
April 7, 2021
SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma Multiforme
David Cerna, Bora Lim, Yusuf Adelabu, et al.
Investigational New Drugs
|
July 18, 2013
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer
William R Schelman, Tabraiz A Mohammed, Anne M Traynor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients
Naoko Takebe, Xiangfei Cheng, Suhlan Wu, et al.
Page
of 14